SpringWorks Therapeutics, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $47,021,000 compared to $19,821,000 a year ago. Interest income, net was $211,000 compared to $157,000 a year ago. Net loss was $47,010,000 compared to $19,893,000 a year ago. Net loss per share, basic and diluted was $0.97 compared to $0.47 a year ago. For the six months, the company reported loss from operations of $76,777,000 compared to $35,951,000 a year ago. Interest income, net was $438,000 compared to $1,093,000 a year ago. Net loss was $76,797,000 compared to $35,187,000 a year ago. Net loss per share, basic and diluted was $1.59 compared to $0.84 a year ago.